LEESBURG, Virginia, Oct. 31, 2019 /PRNewswire/ -- Stryker announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of its SAHARA Lateral 3D Expandable Interbody System featuring

WASHINGTON, Oct. 31, 2019 /PRNewswire/ -- Wounded Warrior Project® (WWP) announced a renewal of grants in support of Elizabeth Dole Founda

RANCHO MIRAGE, Calif., Oct. 31, 2019 /PRNewswire/ -- Today, The Barbara Sinatra Children's Center Foundation in conjunction with Wonder Media announced the launch of the "

CAMBRIDGE, Mass., Oct. 31, 2019 /PRNewswire/ -- TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that it will present nine new research findings at the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

LOS ANGELES and TEL AVIV, Israel, Oct. 31, 2019 /PRNewswire/ -- iCAN: Israel-Cannabis, Israel's leading cannabis incubator and Headquarters (HQ), a Los Angeles based product accelerator and cannabis license holder with distribution and manufacturing facilities, have fo

LAKE FOREST, Calif., Oct. 31, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is proud to announce that it has received Health Canada Certification for multiple new products which will further expand its penetration into the Canadian market. Included in this certification are Morpheu

SARASOTA, Fla., Oct. 31, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of the FDA cleared INVOcell®, the world's only in vivo Intravaginal Culture System, is pleased to share an open letter to shareholders written by its

TAMPA, Fla., Oct. 31, 2019 /PRNewswire/ -- INHIBITOR Therapeutics, Inc. (OTCQB: INTI), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to inhibit the progression of cancerous and non-cancerous proliferation disorders, today announced that Debra Peattie, PhD, MBA has b

BOSTON, Oct. 31, 2019 /PRNewswire/ -- The VHL Alliance (VHLA) today announced the 2019 recipients of the VHLA Competitive Research Grant Program.  This year, three grantees were chosen.  Scientists are increasingly aware that curing von Hippel-Lindau disease, a genetic form of cancer – is a key step to curing cancer, leading to a significant increase in t

GAITHERSBURG, Md., Oct. 31, 2019 /PRNewswire/ -- The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) granted Shreis Scalene Sciences (Shreis), in Gaithersburg, MD, 'Breakthrough Device Designation' for the CYTOTRON® - a CE marked, whole-body therapeutic medical device. "We are confident